Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil effectively treats female pattern hair loss.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

Some chemicals absorbed through the skin can cause serious health problems.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Inositol was not more effective than a placebo in treating trichotillomania.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.